Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Encompass Health CorpEHC · Entity 3460 | Director · President & CEO | August 10, 2026 | August 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Encompass Health Corp
Report date August 10, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Encompass Health Common StockSEC Table I · non-derivative | Direct | 267,814 |
Ending reported balance
After 2026-08-10 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-10 · Sale · Disposed 171,569 · Balance 269,393 F1: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.93 to $125.92, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Row 2 · 2026-08-10 · Sale · Disposed 1,579 · Balance 267,814 F2: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.93 to $126.22, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. |
Filing footnotes · ownership attribution and instrument terms
F1: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.93 to $125.92, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
F2: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.93 to $126.22, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 10, 2026 Filed Aug 11, 2026 18:47 UTC | Encompass Health Corp EHC · Entity 3460 | SaleEncompass Health Common Stock | 1,579 | $126.06 | $199,048.74 |
DisclosureSEC source: 0000785161-26-000191 · wk-form4_1786474034.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 267,814 F2 · price: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.93 to $126.22, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| August 10, 2026 Filed Aug 11, 2026 18:47 UTC | Encompass Health Corp EHC · Entity 3460 | SaleEncompass Health Common Stock | 171,569 | $125.46 | $21,525,046.74 |
DisclosureSEC source: 0000785161-26-000191 · wk-form4_1786474034.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 269,393 F1 · price: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.93 to $125.92, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 17:10 UTC | Encompass Health Corp EHC · Entity 3460 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 35,461 | $108.06 Strike: $108.06 | $3,831,915.66 |
DisclosureSEC source: 0000785161-26-000087 · form4.xml · derivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,461 Underlying: Encompass Health Common Stock · 35,461 shares Expires 2036-03-02 F2 · derivative.exercise_date: The option becomes exercisable in equal annual installments over a three-year period commencing March 2, 2027. Read SEC document |
| February 28, 2026 Filed Mar 3, 2026 17:10 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 2,187 | $107.88 | $235,933.56 |
DisclosureSEC source: 0000785161-26-000087 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 440,962 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 14:33 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 2,488 | $106.15 | $264,101.20 |
DisclosureSEC source: 0000785161-26-000077 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 443,149 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 20, 2026 Filed Feb 23, 2026 20:40 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 1,797 | $106.55 | $191,470.35 |
DisclosureSEC source: 0000785161-26-000061 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 445,637 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 20:41 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 12,796 | $0.00 | $0.00 |
DisclosureSEC source: 0000785161-26-000039 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 490,812 F2 · shares: Annual award of restricted stock pursuant to the Corporation's 2025 Omnibus Performance Incentive Plan. Read SEC document |
| February 19, 2026 Filed Feb 23, 2026 20:40 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 43,378 | $107.15 | $4,647,952.70 |
DisclosureSEC source: 0000785161-26-000061 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 447,434 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 20:41 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 100,946 | $0.00 | $0.00 |
DisclosureSEC source: 0000785161-26-000039 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 478,016 F1 · shares: This issuance of restricted stock is the result of the satisfaction of performance criteria set out in the terms of a performance share unit award made on February 23, 2023. Read SEC document |
| February 11, 2026 Filed Feb 12, 2026 20:40 UTC | Encompass Health Corp EHC · Entity 3460 | SaleEncompass Health Common Stock | 213 | $113.58 | $24,192.54 |
DisclosureSEC source: 0000785161-26-000032 · form4.xml · nonDerivative · entry 7 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 377,070 Read SEC document |
| February 11, 2026 Filed Feb 12, 2026 20:40 UTC | Encompass Health Corp EHC · Entity 3460 | SaleEncompass Health Common Stock | 87,745 | $113.09 | $9,923,082.05 |
DisclosureSEC source: 0000785161-26-000032 · form4.xml · nonDerivative · entry 6 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 377,283 F6 · price: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.58 to $113.52, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| February 11, 2026 Filed Feb 12, 2026 20:40 UTC | Encompass Health Corp EHC · Entity 3460 | SaleEncompass Health Common Stock | 6,057 | $111.89 | $677,717.73 |
DisclosureSEC source: 0000785161-26-000032 · form4.xml · nonDerivative · entry 5 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 465,028 F5 · price: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.55 to $112.53, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| February 11, 2026 Filed Feb 12, 2026 20:40 UTC | Encompass Health Corp EHC · Entity 3460 | SaleEncompass Health Common Stock | 10,954 | $110.92 | $1,215,017.68 |
DisclosureSEC source: 0000785161-26-000032 · form4.xml · nonDerivative · entry 4 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 471,085 F4 · price: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.52 to $111.51, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| February 11, 2026 Filed Feb 12, 2026 20:40 UTC | Encompass Health Corp EHC · Entity 3460 | SaleEncompass Health Common Stock | 15,584 | $110.07 | $1,715,330.88 |
DisclosureSEC source: 0000785161-26-000032 · form4.xml · nonDerivative · entry 3 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 482,039 F3 · price: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.52 to $110.51, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| February 11, 2026 Filed Feb 12, 2026 20:40 UTC | Encompass Health Corp EHC · Entity 3460 | SaleEncompass Health Common Stock | 13,231 | $108.80 | $1,439,532.80 |
DisclosureSEC source: 0000785161-26-000032 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 497,623 F2 · price: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.47 to $109.17, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| February 11, 2026 Filed Feb 12, 2026 20:40 UTC | Encompass Health Corp EHC · Entity 3460 | SaleEncompass Health Common Stock | 16,216 | $108.03 | $1,751,814.48 |
DisclosureSEC source: 0000785161-26-000032 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 510,854 F1 · price: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.47 to $108.45, inclusive. The reporting pers on undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| May 20, 2025 Filed May 20, 2025 21:08 UTC | Encompass Health Corp EHC · Entity 3460 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 62,078 | $0.00 Strike: $44.67 | $0.00 |
DisclosureSEC source: 0001127602-25-015049 · form4.xml · derivative · entry 6 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Encompass Health Common Stock · 62,078 shares Expires 2028-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc. F2 · derivative.underlying_shares: The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc. Read SEC document |
| May 20, 2025 Filed May 20, 2025 21:08 UTC | Encompass Health Corp EHC · Entity 3460 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 56,306 | $0.00 Strike: $35.06 | $0.00 |
DisclosureSEC source: 0001127602-25-015049 · form4.xml · derivative · entry 5 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Encompass Health Common Stock · 56,306 shares Expires 2027-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc. F2 · derivative.underlying_shares: The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc. Read SEC document |
| May 20, 2025 Filed May 20, 2025 21:08 UTC | Encompass Health Corp EHC · Entity 3460 | SaleEncompass Health Common Stock | 118,290 | $121.53 | $14,375,783.70 |
DisclosureSEC source: 0001127602-25-015049 · form4.xml · nonDerivative · entry 4 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 527,070 F1 · price: This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.03 to $121.96, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range. Read SEC document |
| May 20, 2025 Filed May 20, 2025 21:08 UTC | Encompass Health Corp EHC · Entity 3460 | SaleEncompass Health Common Stock | 94 | $120.94 | $11,368.36 |
DisclosureSEC source: 0001127602-25-015049 · form4.xml · nonDerivative · entry 3 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 645,360 Read SEC document |
| May 20, 2025 Filed May 20, 2025 21:08 UTC | Encompass Health Corp EHC · Entity 3460 | Exercise / conversionEncompass Health Common Stock | 62,078 | $44.67 | $2,773,024.26 |
DisclosureSEC source: 0001127602-25-015049 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 645,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2025 Filed May 20, 2025 21:08 UTC | Encompass Health Corp EHC · Entity 3460 | Exercise / conversionEncompass Health Common Stock | 56,306 | $35.06 | $1,974,088.36 |
DisclosureSEC source: 0001127602-25-015049 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 583,376 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 17:18 UTC | Encompass Health Corp EHC · Entity 3460 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 33,086 | $98.45 Strike: $98.45 | $3,257,316.70 |
DisclosureSEC source: 0001127602-25-008218 · form4.xml · derivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,086 Underlying: Encompass Health Common Stock · 33,086 shares Expires 2035-03-04 F1 · derivative.exercise_date: The option becomes exercisable in equal annual installments over a three-year period commencing March 4, 2026. Read SEC document |
| February 28, 2025 Filed Mar 3, 2025 17:07 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 2,187 | $100.14 | $219,006.18 |
DisclosureSEC source: 0001127602-25-007397 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 527,070 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 25, 2025 Filed Feb 26, 2025 21:07 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 2,896 | $100.63 | $291,424.48 |
DisclosureSEC source: 0001127602-25-006832 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 529,257 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 21:07 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 2,488 | $97.53 | $242,654.64 |
DisclosureSEC source: 0001127602-25-006832 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 532,153 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 19:46 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 12,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-006188 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 534,641 F1 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 19:22 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 31,609 | $92.35 | $2,919,091.15 |
DisclosureSEC source: 0001127602-25-000294 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 522,489 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| April 30, 2024 Filed May 1, 2024 15:47 UTC | Encompass Health Corp EHC · Entity 3460 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 25,516 | $0.00 Strike: $29.06 | $0.00 |
DisclosureSEC source: 0001127602-24-013718 · form4.xml · derivative · entry 5 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Encompass Health Common Stock · 25,516 shares Expires 2026-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc. F2 · shares: The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc. Read SEC document |
| April 30, 2024 Filed May 1, 2024 15:47 UTC | Encompass Health Corp EHC · Entity 3460 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 19,460 | $0.00 Strike: $35.83 | $0.00 |
DisclosureSEC source: 0001127602-24-013718 · form4.xml · derivative · entry 4 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Encompass Health Common Stock · 19,460 shares Expires 2025-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc. F2 · shares: The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc. Read SEC document |
| April 30, 2024 Filed May 1, 2024 15:47 UTC | Encompass Health Corp EHC · Entity 3460 | SaleEncompass Health Common Stock | 44,976 | $83.27 | $3,745,151.52 |
DisclosureSEC source: 0001127602-24-013718 · form4.xml · nonDerivative · entry 3 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 554,098 F1 · price: This per share price is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $83.25 to $83.53, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range. Read SEC document |
| April 30, 2024 Filed May 1, 2024 15:47 UTC | Encompass Health Corp EHC · Entity 3460 | Exercise / conversionEncompass Health Common Stock | 25,516 | $29.06 | $741,494.96 |
DisclosureSEC source: 0001127602-24-013718 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 599,074 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2024 Filed May 1, 2024 15:47 UTC | Encompass Health Corp EHC · Entity 3460 | Exercise / conversionEncompass Health Common Stock | 19,460 | $35.83 | $697,251.80 |
DisclosureSEC source: 0001127602-24-013718 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 573,558 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 20:19 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 14,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-007557 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 554,098 F2 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 20:19 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 74,711 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-007557 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 539,309 F1 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 25, 2022. Read SEC document |
| February 25, 2024 Filed Feb 26, 2024 21:28 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 2,895 | $75.25 | $217,848.75 |
DisclosureSEC source: 0001127602-24-006853 · form4.xml · nonDerivative · entry 3 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 464,598 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 24, 2024 Filed Feb 26, 2024 21:28 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 2,256 | $75.25 | $169,764.00 |
DisclosureSEC source: 0001127602-24-006853 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 467,493 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 23, 2024 Filed Feb 26, 2024 21:28 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 2,487 | $75.25 | $187,146.75 |
DisclosureSEC source: 0001127602-24-006853 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 469,749 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| January 02, 2024 Filed Jan 3, 2024 20:04 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 25,159 | $66.72 | $1,678,608.48 |
DisclosureSEC source: 0001127602-24-000348 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 472,236 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 00:44 UTC | Encompass Health Corp EHC · Entity 3460 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 25,330 | $0.00 Strike: $26.55 | $0.00 |
DisclosureSEC source: 0001127602-23-022891 · form4.xml · derivative · entry 3 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Encompass Health Common Stock · 25,330 shares Expires 2024-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc. F2 · shares: The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 00:44 UTC | Encompass Health Corp EHC · Entity 3460 | SaleEncompass Health Common Stock | 25,330 | $71.06 | $1,799,949.80 |
DisclosureSEC source: 0001127602-23-022891 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 497,405 F1 · price: This per share price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $71.00 to $71.23, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 00:44 UTC | Encompass Health Corp EHC · Entity 3460 | Exercise / conversionEncompass Health Common Stock | 25,330 | $26.55 | $672,511.50 |
DisclosureSEC source: 0001127602-23-022891 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 522,735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 2, 2023 18:46 UTC | Encompass Health Corp EHC · Entity 3460 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 49,498 | $0.00 Strike: $56.21 | $0.00 |
DisclosureSEC source: 0001127602-23-008221 · form4.xml · derivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,498 Underlying: Encompass Health Common Stock · 49,498 shares Expires 2033-03-01 F1 · derivative.exercise_date: The option becomes exercisable in equal annual installments over a three-year period commencing March 1, 2024. Read SEC document |
| February 27, 2023 Filed Feb 28, 2023 16:03 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 2,895 | $60.22 | $174,336.90 |
DisclosureSEC source: 0001127602-23-007406 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 497,395 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 16:03 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 2,256 | $60.22 | $135,856.32 |
DisclosureSEC source: 0001127602-23-007406 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,290 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| February 23, 2023 Filed Feb 24, 2023 17:16 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 16,824 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-006976 · form4.xml · nonDerivative · entry 2 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 502,546 F2 · shares: Annual award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan. Read SEC document |
| February 23, 2023 Filed Feb 24, 2023 17:16 UTC | Encompass Health Corp EHC · Entity 3460 | GrantEncompass Health Common Stock | 61,503 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-006976 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 485,722 F1 · shares: This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 24, 2021. Read SEC document |
| February 21, 2023 Filed Feb 22, 2023 22:19 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 2,100 | $62.86 | $132,006.00 |
DisclosureSEC source: 0001127602-23-006548 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,219 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| January 03, 2023 Filed Jan 4, 2023 21:19 UTC | Encompass Health Corp EHC · Entity 3460 | Tax withholdingEncompass Health Common Stock | 14,576 | $59.81 | $871,790.56 |
DisclosureSEC source: 0001127602-23-000479 · form4.xml · nonDerivative · entry 1 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426,319 F1 · shares: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 13:04 UTC | Encompass Health Corp EHC · Entity 3460 | Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 20,449 | $0.00 Strike: $20.07 | $0.00 |
DisclosureSEC source: 0001127602-22-021346 · form4.xml · derivative · entry 3 Tarr Mark J · CIK 0001304057 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Encompass Health Common Stock · 20,449 shares Expires 2023-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc. F3 · shares: The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.